Samsung Bioepis Co., Ltd. vs. REGENERON PHARMACEUTICALS, INC.

Explore the PTAB proceeding IPR2023-01312 filed by Samsung Bioepis Co., Ltd. on 2023-08-18. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-01312

Filing Date

2023-08-18

Accorded Filing Date

2023-08-18

Institution Decision Date

2023-12-08

Last Modified Date

2024-05-24

Proceeding Type

IPR

Termination Date

2024-02-21

Trial Status

Terminated-Adverse Judgment

Parties & Counsel

Petitioner

Samsung Bioepis Co., Ltd.

Represented By

Nimrod, Raymondet al

Patent Owner / Respondent

REGENERON PHARMACEUTICALS, INC.

Represented By

Brausa, Adamet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 16159269

Respondent Patent Number 10464992

External Links

Espacenet

Google Patents

Respondent Inventor Eric FURFINE et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)

Customer Number 191459

Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
41408	David Marsh	202-942-5068
48001	Thomas Triolo	914-847-1612
48921	Stephen Gaudet	914-847-7376
50370	Neil Miyamoto	914-847-7175
50437	Frank Cottingham	914-593-1116
58583	Brian Cocca	914-847-1421
58714	Ilona Gont	914-847-1304
59668	Brandon Schurter	914-847-7000
60281	Aparna Patankar	914-847-5571
61391	Yonghao Hou	914-839-2555
61915	Yongjin Choi	914-847-5384
65789	Margarita Zippin	914-847-5589
65957	Lisa Flanagan	914-847-8175
67881	Eileen Woo	914-847-1246
68046	Elysa Goldberg	914-847-1280
68059	David Mellman	720-391-8767
68136	Christopher Westberg	914-847-7912
71406	Gabriele Amodeo	914-847-3578
73212	Trisha Agrawal	914-313-7694
74751	Casey Donahoe	814-931-8622
76829	Michael Lewis	202-942-6728
77536	Alyson Nickols	640-448-3073
81783	Alice Ho	202-942-6753

Proceeding Documents

Adverse Judgment After Institution of Trial 37 C.F.R. § 42.73(b) ADVRSJUDG

2024-02-21 FILING PARTY: BOARD

Download

3001

Exhibit 3001 Exhibit

2024-02-21 FILING PARTY: BOARD

Download

Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314 Granting Motion for Joinder 35 U.S.C. § 315(c); 37 C.F.R. § 42.122 OTHER

2023-12-08 FILING PARTY: BOARD

Download

Notice: Notice filing date accorded NOTICE

2023-08-30 FILING PARTY: BOARD

Download

1014

Parkins 2000 Exhibit

2023-08-18 FILING PARTY: PETITIONER

Download

Samsung Bioepis Co., Ltd. vs. REGENERON PHARMACEUTICALS, INC.

Proceeding Overview

Parties & Counsel

Petitioner

Samsung Bioepis Co., Ltd.

Represented By

Patent Owner / Respondent

REGENERON PHARMACEUTICALS, INC.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Adverse Judgment After Institution of Trial 37 C.F.R. § 42.73(b) ADVRSJUDG

Exhibit 3001 Exhibit

Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314 Granting Motion for Joinder 35 U.S.C. § 315(c); 37 C.F.R. § 42.122 OTHER

Notice: Notice filing date accorded NOTICE

Parkins 2000 Exhibit

Application for Extension of Patent Term to U.S. Patent No. 7,373,758 Exhibit

Simulect, Physicians' Desk Reference (59th ed., 2005) Exhibit

U.S. Patent No. 8,110,546 to Dix et al. Exhibit

International Publication No. WO 00/75319 to Papadopoulos et al. Exhibit

Dr. Ralph Tarantino curriculum vitae Exhibit

U.S. Patent No. 10,464,992 Exhibit

Kostanski 2004 Exhibit

Chang 2002 Exhibit

Excerpts from Prosecution History of U.S. Application No. 12/833,417 Exhibit

U.S. Patent Publication No. 2004/0265309 to Kandel et al. Exhibit

Herceptin, Physicians' Desk Reference (59th ed., 2005) Exhibit

Raptiva, Physicians' Desk Reference (59th ed., 2005) Exhibit

Excerpts from Prosecution History of U.S. Application No. 14/330,096 Exhibit

Holash 2002 Exhibit

Vial Definition & Meaning, Merriam-Webster Exhibit

McNally 2000 Exhibit

U.S. Patent Publication No. 2004/0197324 to Liu et al. Exhibit

U.S. Patent No. 7,374,758 to Papadopoulos Exhibit

Excerpts from Prosecution History of U.S. Application No. 13/329,770 Exhibit

Ferrara 2005 Exhibit

U.S. Patent Publication No. 2005/0112061 to Holash et al. Exhibit

Excerpts from Prosecution History of U.S. Application No. 13/914,996 Exhibit

Rudge 2005 Exhibit

Declaration of Dr. Ralph Tarantino Exhibit

Response to O.A. of July 13, 2011 in U.S. Application No. 12/835,065 Exhibit

Fraser 2005 Exhibit

File History of U.S. Application No. 16/159,269 Exhibit

Motion : Joinder MOTION

International Publication No. WO 97/04801 to Andya et al. Exhibit

Avastin, Approved Labeling, Center for Drug Evaluation and Research Exhibit

Food and Drug Administration, Guidance for Industry, May 1999 Exhibit

Xolair Label, Physicians' Desk Reference (59th ed., 2005) Exhibit

U.S. Patent No. 6,171,586 to Lam et al. Exhibit

Excerpts from Prosecution History of U.S. Application No. 12/560,885 Exhibit

Remicade, Physicians' Desk Reference (59th ed., 2005) Exhibit

Excerpts from Prosecution History of U.S. Application No. 11/818,463 Exhibit

Excerpts from Prosecution History of U.S. Application No. 15/879,294 Exhibit

Wurm 2004 Exhibit

Excerpts from Prosecution History of U.S. Application No. 10/095,606 Exhibit

Declaration of Daniel B. Dix, Kelly Frye, and Susan Kautz Exhibit

U.S. Patent Publication No. 2003/0138417 to Kaisheva et al. Exhibit

FDA Guidance for Industry, Q6B Specifications, Aug. 1999 Exhibit

Eva Y. Chi et al., 2003 Exhibit

Wulff 2002 Exhibit

U.S. Patent Publication No. 2003/0113316 to Kaisheva et al. Exhibit

Andya 2003 Exhibit

Petition : as filed PETITION

Notice : Power of Attorney NOTICE

Janeway 2001 Exhibit